Brand Inequity in Access to COVID-19 Vaccines
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Schue J, Fesshaye B, Miller E, Singh P, Limaye R Front Public Health. 2024; 12:1412878.
PMID: 39206003 PMC: 11349526. DOI: 10.3389/fpubh.2024.1412878.
Martin R, Maleche A, Gay J, Fatima H BMJ Glob Health. 2024; 9(1).
PMID: 38167259 PMC: 10773420. DOI: 10.1136/bmjgh-2023-013680.
It is not too late to achieve global covid-19 vaccine equity.
Yamey G, Garcia P, Hassan F, Mao W, McDade K, Pai M BMJ. 2022; 376:e070650.
PMID: 35331982 PMC: 8943596. DOI: 10.1136/bmj-2022-070650.
References
1.
Solis Arce J, Warren S, Meriggi N, Scacco A, McMurry N, Voors M
. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021; 27(8):1385-1394.
PMC: 8363502.
DOI: 10.1038/s41591-021-01454-y.
View
2.
Pai M, Olatunbosun-Alakija A
. Vax the world. Science. 2021; 374(6571):1031.
DOI: 10.1126/science.abn3081.
View
3.
Jecker N, Atuire C
. What's yours is ours: waiving intellectual property protections for COVID-19 vaccines. J Med Ethics. 2021; 47(9):595-598.
DOI: 10.1136/medethics-2021-107555.
View
4.
Forman R, Jit M, Mossialos E
. Divergent vaccination policies could fuel mistrust and hesitancy. Lancet. 2021; 397(10292):2333.
PMC: 8169059.
DOI: 10.1016/S0140-6736(21)01106-5.
View
5.
Usher A
. A beautiful idea: how COVAX has fallen short. Lancet. 2021; 397(10292):2322-2325.
PMC: 8494620.
DOI: 10.1016/S0140-6736(21)01367-2.
View